Ablative Solutionsincis A Clinical Stage Medical Device Company Based In Wakefieldmassachusettsfounded In 2011The Company Focuses On Developing Innovative Solutions For Treating Hypertension Using Renal Denervation Technologyits Mission Is To Enhance Patientslives By Targeting The Overactive Sympathetic Nervous Systemwhich Is Linked To Various Health Conditionsincluding Hypertension And Heart Failure The Primary Product Offered By Ablative Solutions Is The Peregrine System Kitwhich Includes The Peregrine Catheter And A Dehydrated Alcohol Drug Productthis System Is Designed To Deliver Diagnostic And Therapeutic Agents To The Renal Artery Areawhere Sympathetic Nerves Are Locatedthe Peregrine System Is Currently Being Studied In Clinical Trials To Assess Its Effectiveness In Treating Uncontrolled Hypertension Ablative Solutions Has Successfully Raised $171 88 Million In Fundingwith Notable Investors Including Biostar Capital And Gilde Healthcarethe Company Is Dedicated To Improving Cardiovascular Health And Aims To Become The Preferred Choice For Renal Denervation Treatments Among Patients And Healthcare Providers
